Website view: onclive.cmail20.com/t/ViewE...
(Note: Moderate use of "Med-Speak" terminology check out: mlanet.org/page/what-did-my... if you need help with translation)
Ibrutinib’s Role as Frontline Therapy in CLL
onclive.createsend1.com/t/j...
A renowned panel of experts consider ibrutinib as the new frontline standard of care for many patients with chronic lymphocytic leukemia.
-
Stratifying Patients With CLL to Frontline Therapy
onclive.createsend1.com/t/j...
In light of molecular testing in chronic lymphocytic leukemia, the panel outlines several frontline therapies and which patients should receive them.
-
Frontline Therapy in CLL: Combination Strategies and MRD
onclive.createsend1.com/t/j...
A comprehensive review of frontline combination strategies in chronic lymphocytic leukemia and minimal residual disease’s coinciding role.
-
Venetoclax + Obinutuzumab: Impact on CLL Management
onclive.createsend1.com/t/j...
Expert clinicians reflect on combination venetoclax + obinutuzumab to treat chronic lymphocytic leukemia as a chemotherapy-free treatment option.
-
Acalabrutinib's Role in Treating Chronic Lymphocytic Leukemia
onclive.createsend1.com/t/j...
Turning to data from ASCEND and ELEVATE-TN, the panel provides perspective on acalabrutinib therapy for patients with chronic lymphocytic leukemia.
-
CLL: Practical Advice on Selecting and Managing Therapy
onclive.createsend1.com/t/j...
Concluding their discussion on next-generation BTK inhibitors, key opinion leaders share insight on the future management of chronic lymphocytic leukemia.
-
If you haven't already done so, please be sure to complete your profile onclive.updatemyprofile.com... So OncLive can send you the updates on topics you prefer.
-
Len